175 related articles for article (PubMed ID: 12478355)
1. Anticardiolipin antibodies in D+ hemolytic uremic syndrome.
te Loo M; van der Velden T; Onland W; van den Heuvel L; Monnens L
Pediatr Nephrol; 2002 Dec; 17(12):1042-6. PubMed ID: 12478355
[TBL] [Abstract][Full Text] [Related]
2. Renal histopathology in the hemolytic-uremic syndrome following shigellosis.
Koster FT; Boonpucknavig V; Sujaho S; Gilman RH; Rahaman MM
Clin Nephrol; 1984 Feb; 21(2):126-33. PubMed ID: 6373079
[TBL] [Abstract][Full Text] [Related]
3. Hemolytic-uremic syndrome (HUS): a clinicopathological study of 15 cases.
Tinaztepe K; Akkök N; Tinaztepe B
Turk J Pediatr; 1993; 35(1):23-36. PubMed ID: 8236514
[TBL] [Abstract][Full Text] [Related]
4. Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion.
Ake JA; Jelacic S; Ciol MA; Watkins SL; Murray KF; Christie DL; Klein EJ; Tarr PI
Pediatrics; 2005 Jun; 115(6):e673-80. PubMed ID: 15930195
[TBL] [Abstract][Full Text] [Related]
5. Elevated anticardiolipin antibodies in schizophrenic patients before and during neuroleptic medication.
Halacheva K; Dimova S; Tolev T; Dimov D; Nikolova M
Psychiatry Res; 2009 Aug; 169(1):51-5. PubMed ID: 19596154
[TBL] [Abstract][Full Text] [Related]
6. [T and B lymphocytes and NK cells in hemolytic uremic syndrome].
Pérez N; Lasarte P; Bibiloni N; Dejean C; Spizzirri F
Medicina (B Aires); 1991; 51(3):233-7. PubMed ID: 1821906
[TBL] [Abstract][Full Text] [Related]
7. [Recurrent hemolytic-uremic syndrome with positive immunofluorescence].
Schabel F; Mitterstieler G; Dittrich P; Hackl M; Resch R; Stühlinger W
Padiatr Padol; 1985; 20(1):69-75. PubMed ID: 3883294
[TBL] [Abstract][Full Text] [Related]
8. [Hemolytic uremic syndrome by Streptococcus pneumoniae].
Herrero-Morín JD; Fernández N; Santos F; Rey C; Málaga S
Nefrologia; 2007; 27(4):505-8. PubMed ID: 17944589
[TBL] [Abstract][Full Text] [Related]
9. Anticardiolipin antibodies in classic pediatric hemolytic-uremic syndrome: a possible pathogenic role.
Ardiles LG; Olavarría F; Elgueta M; Moya P; Mezzano S
Nephron; 1998; 78(3):278-83. PubMed ID: 9546687
[TBL] [Abstract][Full Text] [Related]
10. Anticardiolipin, other antiphospholipid antibody tests and diagnosis of the antiphospholipid syndrome.
Smikle M; Wharfe G; Fletcher H; Reid M; Roye-Green K; Fredrick J; Pierangeli S
Hum Antibodies; 2003; 12(3):63-6. PubMed ID: 14646034
[TBL] [Abstract][Full Text] [Related]
11. [Presence and significance of anticardiolipin antibodies in infectious diseases].
Barrile A; Quattrocchi P; Bonanno D; Crisafi A; Staiti A; Magaraci G; Romano S; Sturniolo G; Ricciardi R; Ferlazzo B
Recenti Prog Med; 1992 Jun; 83(6):350-3. PubMed ID: 1496184
[TBL] [Abstract][Full Text] [Related]
12. Antiphospholipid antibodies in patients with autoimmune blistering disease.
Echigo T; Hasegawa M; Inaoki M; Yamazaki M; Sato S; Takehara K
J Am Acad Dermatol; 2007 Sep; 57(3):397-400. PubMed ID: 17637483
[TBL] [Abstract][Full Text] [Related]
13. [Connections between ischemic heart disease and anti-cardiolipin antibody positivity].
Ferlazzo B; Bonanno D; Quattrocchi P; Paino AM; Arrigo F
Minerva Cardioangiol; 1993 Apr; 41(4):113-7. PubMed ID: 8332265
[TBL] [Abstract][Full Text] [Related]
14. Antibodies to beta2-glycoprotein-I: relation of anticardiolipin antibodies with clinical and laboratory parameters in patients with systemic lupus erythematosus.
Sahin M; Duzgun N; Tunc SE; Tutkak H
Clin Biochem; 2007 May; 40(8):526-30. PubMed ID: 17359958
[TBL] [Abstract][Full Text] [Related]
15. [Clinical study of anti-phospholipid antibody in patients with sarcoidosis].
Ito S; Ina Y; Hashiba H; Takada K; Sato T; Sato S; Sahashi K; Yamamoto M; Miyachi A; Morishita M
Nihon Kyobu Shikkan Gakkai Zasshi; 1994 Jan; 32(1):3-8. PubMed ID: 8114370
[TBL] [Abstract][Full Text] [Related]
16. Renal transplantation in patients with hemolytic uremic syndrome: high rate of recurrence and increased incidence of acute rejections.
Artz MA; Steenbergen EJ; Hoitsma AJ; Monnens LA; Wetzels JF
Transplantation; 2003 Sep; 76(5):821-6. PubMed ID: 14501861
[TBL] [Abstract][Full Text] [Related]
17. Identification of thrombin antibodies in patients with antiphospholipid syndrome.
Miesbach W; Matthias T; Scharrer I
Ann N Y Acad Sci; 2005 Jun; 1050():250-6. PubMed ID: 16014540
[TBL] [Abstract][Full Text] [Related]
18. [Hemolytic-uremic syndrome].
Bláhová K
Vnitr Lek; 2004 Jul; 50(7):519-25. PubMed ID: 15323259
[TBL] [Abstract][Full Text] [Related]
19. [Hemolytic-uremic syndrome in Chile: clinical features, evolution and prognostic factors].
Zambrano O P; Delucchi B A; Cavagnaro S F; Hevia J P; Rosati M MP; Lagos R E; Nazal Ch V; González C C; Barrera B P; Alvarez L E; Pinto S V; Salas del C P; Cano Sch F; Contreras M A; Galanti de la P M; Gana A JC; Zamorano C J; Espinoza B A; Dreves R P; Pereira M J; Bidegain S A; Pasten P E; Yáñez P L; Cerda F V; Rodríguez S E; Aglony I M; Gutiérrez I E; Salas P F; Figueroa Y S; Valenzuela A M; Grandy H J; Guerra A B; Lapadula A M; Reutter de la M P; Gallardo T V; Maldonado S D; Azócar P M; Cavada Ch G
Rev Med Chil; 2008 Oct; 136(10):1240-6. PubMed ID: 19194619
[TBL] [Abstract][Full Text] [Related]
20. Antiphospholipid antibody ELISAs: survey on the performance of clinical laboratories assessed by using lyophilized affinity-purified IgG with anticardiolipin and anti-beta2-Glycoprotein I activity.
Pengo V; Biasiolo A; Bison E; Chantarangkul V; Tripodi A;
Thromb Res; 2007; 120(1):127-33. PubMed ID: 17020782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
